Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics Study Of Rivaroxaban and Apixaban in Cancer Patients

NCT05819736 is registered in ClinicalTrials.gov with Groupe Hospitalier Pitie-Salpetriere as lead sponsor.

NCT NCT05819736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05819736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics Study Of Rivaroxaban and Apixaban in Cancer Patients
Lead sponsor
Groupe Hospitalier Pitie-Salpetriere
Phase
Observational
Overall status
Completed
Start date
December 1, 2022
Completion date
May 18, 2026
Enrollment
193 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants and thrombotic disorders